LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients

LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution

(2011) H. E. Barker et al.   CANCER RESEARCH

Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas

(2011) Gema Moreno-Bueno et al.   EMBO Molecular Medicine

Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2

(2010) Vera Brekhman et al.   FASEB JOURNAL

The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin

(2010) Young-Mi Kim et al.   MOLECULAR BIOLOGY REPORTS

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

(2010) Vivian Barry-Hamilton et al.   NATURE MEDICINE

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion

(2009) Vera Brekhman et al.   BMC CANCER

Novel therapeutic approaches to the treatment of metastatic breast cancer

(2009) Yolanda Fernández et al.   CANCER TREATMENT REVIEWS

Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway

(2009) Liang Peng et al.   CARCINOGENESIS

Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells

(2009) Peter Hollosi et al.   INTERNATIONAL JOURNAL OF CANCER

Functional analysis of LOXL2 in pancreatic carcinoma

(2009) Felix Rückert et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Lysyl Oxidase-Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas

(2008) H. Peinado et al.   CANCER RESEARCH

TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles

(2008) Hanne Offenberg et al.   Molecular Oncology